Controversies in Targeted Drug Delivery
Intrathecal drug delivery is a well-established intervention for chronic pain and severe spasticity with over 3 decades of clinical use. Safe and effective utilization of this technique requires solid technical skills. The purpose of this course will be to describe the subtleties and controversies regarding intrathecal drug delivery. Multiple medical specialists would find this course of interest including neurology, neurosurgery, anesthesiology and physical medicine and rehabilitation. This course will also be of interest to many allied health professionals such as physical therapy, occupational therapy, nursing, pharmacy, case management and bioengineering.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Understand the gaps and barriers that limit patient access to neuromodulation services
- Gain insight into the potential role in interleukin-10 as intrathecal agent
Related items
- Accelerating Non-Pain Physician Awareness of the Role of Neuromodulation: A Discussion in Healthcare Delivery Science
- Partnering with our Patients to Optimize Outcomes
- Neuromodulation and Neurosurgical Mentorship and Educational Development
- Plenary Session III: Late-Breaking Clinical Trials
- Spinal Cord Stimulation Mechanisms: Results from Animal Studies
- Faculty:
Michael F. Saulino, MD,PhD
Erik Shaw, DO
Linda R. Watkins, PhD
Jay S. Grider, DO,PhD, MBA
Gerald Bilsky, MD
Jonathan M. Hagedorn, MD